|

NK510 Clinical Trials

1 actively recruiting trial

Pipeline

Early 1: 1

Top Sponsors

  • Base Therapeutics (Shanghai) Co., Ltd.1

Indications

  • NSCLC1
  • Cancer1

Other1 trial

Safety and Efficacy of NK510 to Treat NSCLC
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.